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Abstract There is increasing evidence that depression
derives from the impact of environmental pressure on
genetically susceptible individuals. We analyzed the
effects of chronic mild stress (CMS) on prefrontal cor-
tex transcriptome of two strains of mice bred for high
(HA)and low (LA) swim stress-induced analgesia that
differ in basal transcriptomic profiles and depression-
like behaviors. We found that CMS affected 96 and 92
genes in HA and LA mice, respectively. Among genes
with the same expression pattern in both strains after
CMS, we observed robust upregulation of Ttr gene
coding transthyretin involved in amyloidosis, seizures,
stroke-like episodes, or dementia. Strain-specific HA
transcriptome affected by CMS was associated with
deregulation of genes involved in insulin secretion
(Acvr1c, Nnat, and Pfkm), neuropeptide hormone activ-
ity (Nts and Trh), and dopamine receptor mediated
signaling pathway (Clic6, Drd1a, and Ppp1r1b). LA
transcriptome affected by CMS was associated with
genes involved in behavioral response to stimulus
(Fcer1g, Rasd2, S100a8, S100a9, Crhr1, Grm5, and
Prkcc), immune effector processes (Fcer1g, Mpo, and
Igh-VJ558), diacylglycerol binding (Rasgrp1, Dgke,
Dgkg, and Prkcc), and long-term depression (Crhr1,
Grm5, and Prkcc) and/or coding elements of dendrites
(Crmp1, Cntnap4, and Prkcc) and myelin proteins
(Gpm6a, Mal, and Mog). The results indicate significant
contribution of genetic background to differences in
stress response gene expression in the mouse prefrontal
cortex.
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Introduction
Exposure to stress is thought to precipitate several neuro-
psychiatric disorders (Mazure et al. 1995). Chronic stress
has significant impact on the cellular integrity and function
of certain brain areas, most notably the limbic structures
(Joels et al. 2007; McEwen 2006). In most studies, the
hippocampal formation has been investigated as a crucial
structure, but recently the prefrontal cortex (PFC) has been
seen as equally important (Czeh et al. 2008).
Prefrontal cortex in rodents participates in the higher-
order functions including learning, memory, event associa-
tion, the temporal sequencing of tasks, specific aspects of
locomotor activity, spatial navigation, decision making, and
goal-directed behavior (Pirot et al. 1994; Vertes 2006). PFC
plays a key role in working memory, recalling memories
from long-term storage, as well as recent memories to guide
behavior, while inhibiting inappropriate responses and dis-
tractions (Ramos and Arnsten 2007; Robbins 1996). All of
these abilities depend on proper PFC network connections,
which are vulnerable to stress and neurochemical environ-
ment (Arnsten 2009). PFC contributes to negative feedback
control of the hypothalamic–pituitary–adrenal axis (HPA)
(Herman et al. 2003) and regulates the stress responses of
other structures (Amat et al. 2005; Pascucci et al. 2007).
Based on observations from clinical, neuropsychological,
and neuroimaging studies, dysfunction of the PFC has been
suspected to be accountable for some depressive symptoms
(Cummings 1992; Deutch 1993; Fibiger 1995). Dolan et al.
(1994) have provided evidence that neuropsychological
symptoms in depression are associated with profound hypo-
metabolism, particularly involving the medial PFC (Dolan
et al. 1994). Both bipolar and unipolar affective disorders
can be identified by decreases in cerebral blood flow
and the rate of glucose metabolism in the PFC (Drevets
2000; Drevets et al. 1997).
Animal studies indicate that exposure to acute or chronic
stress can alter the activity of the neuroendocrine and neu-
rotransmitter systems that affect behavior. Stress in rodents
induces anxiety, enhanced fear, anhedonia, and depression
(Bekris et al. 2005; Bergstrom et al. 2008; D’Aquila et al.
1994; Wood et al. 2008). Chronic stress reduces dopaminer-
gic and serotonergic transmission in the PFC (Mizoguchi et
al. 2002) and results in a depressive state. Exposure to mild
uncontrollable stress impairs PFC functions in humans and
animals (Arnsten 2009). Loss of self-control during stress
can lead to maladaptive behaviors such as alcohol and drug
addiction, smoking, and overeating (Li and Sinha 2008).
Stress can also exacerbate the symptoms of bipolar disorders
and schizophrenia (Breier et al. 1991; Dohrenwend 1994).
Preclinical observations can help to understand stress-
related processes in the human brain of genetically stress-
vulnerable individuals. Because the responses should differ
between the subjects displaying different sensitivity to
stress, in the present study we investigated the effects of
chronic mild stress (CMS) on gene expression in the frontal
cortex of mice selected for high (HA strain) or low (LA
strain) stress reaction measured by magnitude of swim
stress-induced analgesia (Panocka et al. 1986b). The un-
stressed strains display profound differences in a number
of behavioral tests reflecting anxiety or depression. HA mice
exhibit higher acoustic startle response (Błaszczyk et al. 2000;
Juszczak et al. 2008a) and longer depression-like behavior
(immobility) in the tail suspension (TST) and forced swim
(FST) tests (Juszczak et al. 2008b, 2006; Panocka et al. 2001)
than the LA strain. The strains also differ in responses to a
variety of antidepressants. Desipramine (a prototypic tricylic
antidepressant), venlafaxine (selective serotonin reuptake in-
hibitor), and aminosenktide (tachykinin NK3—receptor ago-
nist) shortened the immobility time of HA mice in the FST or
TST, but were ineffective in the LA strain (Juszczak et al.
2006; Panocka et al. 2001).
Using gene expression profiling and bioinformatics
methodology we now attempted to identify candidate genes,
physiological pathways, and potential mechanisms of mood
disorders in the PFC of mice that differ in depression-like
responses and are exposed to CMS.
Experimental Procedures
Animals
Male Swiss Webster mice (weighing 25–30 g, 12 weeks of
age), from two lines selected for 76 generations for high
(HA) and low (LA) swim stress-induced analgesia (SIA)
were used (Panocka et al. 1986a). Adult males and females
from each generation, after completion of 3-min swim in
20 °C water, were tested for pain sensitivity on a hot-plate
heated to 56 °C. Latency of characteristic hind paw flick or
lick response was scored. The animals displaying the lon-
gest (50–60 s) and the shortest (<10 s) post-swim latencies
of the nociceptive response were chosen for further breeding.
Animals were given ordinary daily care with free access to
food and water and kept at ambient temperature of 22±1 °C.
All procedures had been approved by the Local Ethics Com-
mission and carried out in accordance with the Guiding Prin-
ciples for the Care and Use of Research Animals.
Chronic Mild Stress
The animals were assigned to two treatment groups. Control
animals (control HA mice, n015, and control LA mice, n0
15) were given ordinary daily care with free access to food
and water, while the stressed animals were exposed for
5 weeks to chronic mild stress (CMS HA mice, n015, and
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CMS LA mice, n015). CMS was adapted from the proce-
dures developed by Willner et al. (1987) and used in our
previous study, Lisowski et al. (2011). Stressors were ap-
plied in a pseudo-random manner during both light and dark
phases. All mice received the same treatment schedule, with
treatments occurring in different orders in different weeks.
The control and CMS groups of mice were housed in single
cages and separately in different rooms.
Sample Preparation
Two days after the end of the CMS, the animals were gently
removed from their cages and quickly decapitated within
30 s, the brains were removed and placed on ice-cold glass
dish, and prefrontal cortices were immediately isolated
(Hamon 2006), aliquoted into freezing vials, frozen in liquid
nitrogen, and stored at −80 °C until analysis. Total RNAwas
isolated, separately from each prefrontal cortex, using
NucleoSpin RNA II kit (Macherey-Nagel, Germany),
according to the manufacturer's protocol. Nanodrop (Nano-
drop, USA) and Bioanalyzer (Agilent, USA) estimated
quantity and quality of each RNA sample, and the RIN
(RNA Integrity Number) index ranged from 9.4 to 9.8 for
all samples.
For each microarray, total RNA samples from five ani-
mals were pooled and quantity and quality of the pooled
samples estimated once again by the Nanodrop and Bioana-
lyzer. Biotinylated cRNA was prepared using the Illumina
RNA Amplification Kit (Ambion Inc., USA) according to
the manufacturer's protocol and starting with 100 ng total
RNA. Samples were purified with the RNeasy kit (Qiagen,
Germany) according to the manufacturer's protocol.
Microarray, Hybridization, and Fluorescent Detection
Hybridization to the Sentrix MouseRef-8 Expression Bead-
Chip (Illumina, USA), washing, and scanning were per-
formed according to the Illumina BeadStation 500×
manual. Sentrix MouseRef-8 Expression BeadChip contains
approximately 24,000 well-annotated RefSeq 50-mer oligo-
nucleotide probes per array. Data were extracted using soft-
ware provided by the manufacturer. Illumina Beadstudio v2
software with the default settings for gene expression analysis
was used.
Data Normalization and Selection of Differentially Expressed
Genes
Raw microarray data were processed with BeadArray and
LIMMA package of the Bioconductor project (Bioconductor
project; www.bioconductor.org). Data preprocessing step in-
volved normalization of expression levels with quantile meth-
od was preceded by log2 transformation. Linear model fitting
was performed for the pre-processed dataset. The empirical
Bayes analysis was performed in order to identify differen-
tially expressed genes by testing whether the contrast coeffi-
cients from the linear models can be assumed equal zero.
Genes considered to be significantly differentially expressed
with logged fold-change are greater than 0.5 and adjusted p
value is less than 0.05. Benjamini and Hochberg method
(1995), for controlling false discovery rate, was used to correct
p values.
Bioinformatics, Database Search, and Gene Enrichment
Analysis
Gene Ontology Analysis
Gene lists (GenBank accession numbers) from microarray
results were submitted to the Expression Analysis Systemic
Explorer (EASE; http://david.abcc.ncifcrf.gov). EASE takes
into account the frequencies of genes belonging to particular
Gene Ontology terms (GO; http://www.geneontology.org/
index.shtml) among the genes found to be regulated and
among all genes studied in the experiment. EASE performs
statistical analysis to detect overrepresented functional gene
categories in the data set compared with all genes on the
arrays. GO terms are reported with corresponding EASE
scores—it is a conservative statistical test that gives the
upper bound of the distribution of the Jackknife Fisher exact
probabilities and favors robust categories. Functional gene
categories were considered significantly overrepresented
at p<0.05. Genes to functional categories were classified
with biological process, molecular function, and cellular
component ontologies.
KEGG Biochemical Pathways Analysis
Analysis of the genes' association with physiological path-
ways was performed using the Kyoto Encyclopedia of Genes
and Genomes database (KEGG; http://www.genome.jp/kegg/
pathway.html). In KEGG database, distributions of the differ-
entially expressed genes were classified among biochemical
pathways. Microarray data from a single gene in a pathway do
not suffice to describe a regulatorymechanism of the pathway.
Therefore, only pathways with the microarray information for
at least two genes were considered. To identify significantly
overrepresented biological categories and KEGG pathways
within the lists of differentially expressed genes, the threshold
of EASE Score for the enrichment analysis was set at p≤0.05.
Functional Clustering
For a more insightful view of the relationships between
annotation categories compared with chart, genes were clus-
tered in the DAVID 6.7 Functional Annotation Clustering
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module (http://david.abcc.ncifcrf.gov/). Biologically mean-
ingful clusters consist of genes that are annotated into spe-
cific functional annotation groups. Grouping genes based on
functional similarity can systematically enhance biological
interpretation of large lists of genes derived from high
throughput studies. The Functional Classification Tool gen-
erates a gene-to-gene similarity matrix based on shared
functional annotation using over 75,000 terms from 14
functional annotation sources. DAVID clustering algorithms
classifies highly related genes into functionally related
groups. The classification stringency of the cluster analysis
was set at “high” level. To avoid over-counting duplicated
genes in the chart report view, the Fisher exact statistics was
calculated based on corresponding DAVID gene IDs by
which all redundancies in original IDs are removed.
Quantitative Real-Time Reverse Transcription PCR
To validate the results of microarrays, quantitative real-time
RT-PCR (qPCR) with SYBR Green technique was per-
formed as described previously (Lisowski et al. 2011). Sev-
en genes belonging to different functional groups and
significantly differing in expression between the control
and CMS mice of each strain were selected. qPCR assays
were carried out in triplicates on the same but non-pooled
individual RNA samples (n015) per experimental group
RNA samples, which were used in the microarray experi-
ment. For reference, two housekeeping genes, selected from
ten commonly used reference genes using previous meth-
odology (Lisowski et al. 2008a, b) stably expressed in
mouse hippocampus in applied experimental assay and
belonging to different functional classes, were used:
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and
hypoxanthine guanine phosphoribosyl transferase 1
(Hprt1). Primers were designed using ExonPrimer software
(http://ihg2.helmholtz-muenchen.de/ihg/ExonPrimer.html)
(Institute of Human Genetics, TUM/Helmholtz Center
Munich, Germany) using Mus musculus GenBank
sequences. All primers produced amplicons which
spanned two exons each in highly conserved coding
regions and included all known alternatively spliced
mRNA variants
Data from three runs were calibrated by calculating the
average cycle threshold value over samples in each run and
the results were calculated using the mathematical model for
relative quantification in qPCR described by Pfaffl (2001).
To test for the effects of the observational groups on target
genes mRNA level, t-test was performed (SAS version 8.02;
SAS Institute, NC). Results are reported as the mean ±
standard error of the mean (SEM). Differences between the
groups were considered significant at p<0.05. The degree of
significance and the correlation between fold changes, as
determined in the microarray analysis and those determined
by qPCR, was evaluated with the Pearson moment
correlation.
Results
Expression profiling was designed to determine the impact
of genetic background (two selectively bred strains) on the
transcriptional effects of CMS in prefrontal cortex. Gene
analysis was performed by one color hybridization of the
24 K microarray in HA and LA, naïve and CMS mice. Three
independent biological replicates of microarray were pre-
pared for each group of mice. To minimize the influence of
individual differences between the animals and variation
introduced by dissection and tissue preparation, total RNA
separately isolated from several PFCs was pooled. Each
pool, containing total RNA from five individuals, was sep-
arately converted to cRNA and hybridized to a single
microarray.
The identified genes are considered to be expressed in the
prefrontal cortex according to Novartis Gene Expression
Atlas (http://www.biogps.gnf.org/). Cell-type classification
analysis of differentially expressed genes, according to Cahoy
(2008), GeneCards Database (http://www.genecards.org/)
screening and Ingenuity Pathway Analysis (IPA) (http://
www.ingenuity.com/) of top canonical pathways, revealed
that most of them are characteristic for neurons and
oligodendrocytes.
Differences in Basal Gene Expression of HAMice Compared
to LA
Comparison of basal gene expression profiles between the
HA and LA strains identified 193 transcripts with different
levels of mRNA in the PFC that met the criteria of logged
fold change greater than 0.5 and p<0.05. One hundred
thirty-three of differentially expressed genes between the
strains were upregulated and 60 genes were downregulated
in HA as compared to LA. Expression of these genes differs
at baseline in a genotype-dependent manner. The whole sets
of probes that differed in naive HA vs. LA mice are pre-
sented in “Electronic Supplementary Material” (ESM) Table
S1. Genes annotated to these probe sets were considered to
be expressed in the examined brain tissue according to
Novartis Gene Expression Atlas (www.biogps.gnf.org).
Statistically significant (p<0.05) over-expressed biological
processes terms associated with the up- and downregulated
genes between strains were found with the DAVID Functional
Annotation Tool. We identified functional categories of bio-
logical process (Fig. 1), molecular function (Fig. 2), and
KEGG biochemical pathways terms (Fig. 3), including ele-
ments of neuron development and differentiation, dendrite
development, protein transport and localization, lipid binding,
36 J Mol Neurosci (2013) 50:33–57
calcium ion binding, phosphoinositide binding, cytoskeletal
regulatory protein binding, long-term potentiation, VEGF,
MAPK, and/or T cell signaling pathways.
GO and KEGG classifications on a list of significant upre-
gulated transcripts was done in each strain. In general, genes
upregulated in HA encode elements involved in processes
such as dendrite development (Mtap2, Mtap1b, and Pak1),
neuron projection (Mtap2, Mtap1b, Stxbp1, Etv1, and Pak1),
cell communication (Kif1b, Snx14, Snx17, Clstn1, Stxbp1,
Snx2, and Ppp3ca), synaptic transmission (Kif1b, Clstn1,
Fig. 2 Significantly enriched (p<0.05) gene ontology (GO) molecular function categories of differentially expressed genes in the prefrontal cortex
of naïve high analgesia (HA) vs. naïve low analgesia (LA) mice
Fig. 1 Significantly enriched (p<0.05) gene ontology (GO) biological process categories of differentially expressed genes in the prefrontal cortex
of naïve high analgesia (HA) vs. naïve low analgesia (LA) mice
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Stxbp1, and Ppp3ca), lipid binding (Snap91, Dgke, Snx14,
Rasgrp1, Snx17, Snx2, Prkcc, and Sh3gl2), and calcium ion
binding (Atp2c1, Rasgrp1, Itgav, Clstn1, Cacng3, Kcnip2,
Capn2, Prkcc, 1500003003rik, and Dtna) (Tables 1 and 2).
To find significantly over-represented pathways in the list
of differentially expressed genes, we searched the KEGG
database. In the HA mice prefrontal cortex, significantly
overrepresented pathways were the long-term potentiation,
Fig. 3 Significantly enriched (p<0.05) Kyoto Encyclopedia of Genes and Genomes (KEGG) biochemical pathways of differentially expressed
genes in the prefrontal cortex of naïve high analgesia (HA) vs. naïve low analgesia (LA) mice
Table 1 Upregulated genes associated with the gene ontology (GO) biological process terms (p<0.05) in the prefrontal cortex of high analgesia
(HA) mice
GO biological process Number of genes EASE score Genes
Endocytosis 6 0.002 CAV2, ITGAV, SNX17, STXBP1, SH3GL2, ELMO1
Membrane organization 7 0.002 CAV2, SNAP91, ITGAV, SNX17, STXBP1, SH3GL2, ELMO1
Organelle organization 12 0.014 TSPYL1, EPB4,1L3, CAV2, SNAP91, ATP2C1, MTAP2, MTAP1B,
STXBP1, CBX3, ACIN1, RBBP7, ELMO1
Transport 20 0.016 GDI1, CAV2, SNAP91, SNX14, KCNAB1, SNX17, STXBP1, SNX2,
ATP6V1G2, CACNG3, KCNIP2, ELMO1, RAB7, SLCO1A4,
KIF1B, ATP2C1, ITGAV, PPP3CA, SH3GL2, SEC61A2
Dendrite development 3 0.016 MTAP2, MTAP1B, PAK1
Establishment of localization 20 0.017 GDI1, CAV2, SNAP91, SNX14, KCNAB1, SNX17, STXBP1, SNX2,
ATP6V1G2, CACNG3, KCNIP2, ELMO1, RAB7, SLCO1A4,
KIF1B, ATP2C1, ITGAV, PPP3CA, SH3GL2, SEC61A2
Cellular component organization 17 0.018 CAV2, SNAP91, MTAP2, SNX17, STXBP1, CBX3, RBBP7, ELMO1,
TSPYL1, EPB4,1L3, ATP2C1, ITGAV, MTAP1B, ETV1, PAK1,
ACIN1, SH3GL2
Neuron projection 5 0.023 MTAP2, MTAP1B, STXBP1, ETV1, PAK1
Vesicle-mediated transport 7 0.027 CAV2, SNAP91, ITGAV, SNX17, STXBP1, SH3GL2, ELMO1
Cell communication 7 0.028 KIF1B, SNX14, SNX17, CLSTN1, STXBP1, SNX2, PPP3CA
Protein transport 8 0.040 GDI1, SNX14, SNX17, STXBP1, SNX2, PPP3CA, SEC61A2, RAB7
Synaptic transmission 4 0.040 KIF1B, CLSTN1, STXBP1, PPP3CA
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focal adhesion, NK mediated cytotoxicity, VEGF, MAPK, T
cell receptor, axon guidance, regulation of actin cytoskele-
ton, apoptosis, Fc gamma R-mediated phagocytosis and
Alzheimer's disease pathways (Table 3).
Genes upregulated in LA are involved in neuron differ-
entiation (Sema5a, Exoc7, Pcsk9, and Rpgrip1), response to
stimulus (Crhr1, Bat5, Ercc5, S100a8, Camp, S100a9,
Pcsk9, Mpo, Rpgrip1, and Psmb9), structural constituent
of ribosome (Mrps18c, Rpl6, and Rps15a), and coding cel-
lular components such as cytosol and cytoplasmic parts
(Actb, Bat5, Exoc7, Camp, Rps15a, Psmb9, Mrps18c,
Rpl6, Tor1b, Pcsk9, Ltf, Mpo, Neu1, Pdrg1, Tomm22,
Slc4a1, Hbb-b2, and Srp9), cell cortex parts (Actb, Exoc7,
and Slc4a1), macromolecular complex (Bat5, Mrps18c,
Kif3a, Exoc7, Rpl6, Rps15a, Pdrg1, Hbb-b2, Srp9, Itgbl1,
and Psmb9), secretory granule and cytoplasmic membrane-
bounded vesicle (Camp, Mpo, Ltf, and Neu1), and ribosome
(Mrps18c, Rpl6, and Rps15a) (Tables 4 and 5). Among the
genes upregulated in LA mice, no statistically significant
KEGG biochemical pathways were found.
Effects of Chronic Mild Stress on Gene Expression in HA
and LA Mice
The influence of genetic background on gene expression
level was estimated. Using the same statistical criteria, the
Table 2 Upregulated genes associated with the gene ontology (GO) molecular function terms (p<0.05) in the prefrontal cortex of high analgesia
(HA) mice
GO molecular function Number of genes EASE score Genes
Lipid binding 8 0.002 SNAP91, DGKE, SNX14, RASGRP1, SNX17, SNX2, PRKCC,
SH3GL2
Phosphoinositide binding 4 0.006 SNAP91, SNX14, SNX17, SNX2
Cytoskeletal regulatory protein binding 2 0.017 MTAP2, MTAP1B
Phospholipid binding 4 0.024 SNAP91, SNX14, SNX17, SNX2
Calcium ion binding 10 0.025 ATP2C1, RASGRP1, ITGAV, CLSTN1, CACNG3, KCNIP2,
CAPN2, PRKCC, 1500003O03RIK, DTNA
Protein binding 39 0.026 CAV2, SNAP91, SNX14, SNX17, CLSTN1, SNX2, CBX3,
ATP6V1G2, COPS8, ARPC5, FBXW7, SFRS5, CASP9,
ITGAV, INSIG1, BTBD3, ZFP238, PPP3CA, PAK1, RNF14,
SEC61A2, DTNA, MTAP2, EEF1A2, STXBP1, CAPN2,
RBBP7,
PPP1CB, ELMO1, EPB4,1L3, MAPK1, ATF4, KIF1B, BTG1,
MTAP1B, LASS1, HSPD1, CD200, SH3GL2
Diacylglycerol binding 3 0.035 DGKE, RASGRP1, PRKCC
Table 3 Upregulated genes associated with the Kyoto Encyclopedia of Genes and Genomes (KEGG) biochemical pathways (p<0.05) in the
prefrontal cortex of high analgesia (HA) mice
KEGG biochemical pathway Number of genes EASE score Genes
Long-term potentiation 6 0.000 MAPK1, ATF4, PPP3CA, PPP1CB, PRKCC,
1500003O03RIK
Natural killer cell-mediated cytotoxicity 6 0.001 MAPK1, H2-T23, PPP3CA, PAK1, PRKCC,
1500003O03RIK
MAPK signaling pathway 8 0.001 MAPK1, ATF4, RASGRP1, CACNG3, PPP3CA, PAK1,
PRKCC, 1500003O03RIK
Focal adhesion 7 0.001 MAPK1, CAV2, ITGAV, PAK1, CAPN2, PPP1CB, PRKCC
VEGF signaling pathway 5 0.001 MAPK1, CASP9, PPP3CA, PRKCC, 1500003O03RIK
T cell receptor signaling pathway 5 0.004 MAPK1, RASGRP1, PPP3CA, PAK1, 1500003O03RIK
Apoptosis 4 0.014 CASP9, PPP3CA, CAPN2, 1500003O03RIK
Alzheimer's disease 5 0.015 MAPK1, CASP9, PPP3CA, CAPN2, 1500003O03RIK
Fc gamma R-mediated phagocytosis 4 0.017 MAPK1, PAK1, ARPC5, PRKCC
Regulation of actin cytoskeleton 5 0.036 MAPK1, ITGAV, PAK1, ARPC5, PPP1CB
Axon guidance 4 0.038 MAPK1, PPP3CA, PAK1, 1500003O03RIK
Amyotrophic lateral sclerosis (ALS) 3 0.042 CASP9, PPP3CA, 1500003O03RIK
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comparisons of PFC transcriptomic profiles of naive vs.
CMS animals revealed 96 in HA and 92 in LA differentially
expressed transcripts. In HA strain, 59 of differentially
expressed were upregulated and 37 genes were downregu-
lated after CMS (ESM Table S2), while in LA strain, 60
genes were upregulated and 32 were downregulated as a
result of CMS (ESM Table S3). There was also some over-
lap in the expression profiles between the strains: 23 com-
mon transcripts were changed in both strains (Table 6).
Within the list of the overlapping genes, according to DA-
VID Functional Clustering Tool, eight genes coded cell
membrane parts (Rab5b, Cntnap4, Ai593442, Pigt, Tomm22,
Rgs9, Rasd2, and Calb2), six genes were classified into signal
transduction and intracellular signaling cascade cluster
(Rab5b, Cntnap4, Dgkg, Rgs9, Mtss1l, and Rasd2), three
genes into ion binding cluster (Dgkg, Nell2, and Calb2), and
three genes into transport and establishment and localization
cluster (Ttr, Rab5b, and Tomm22) (Table 7).
Statistically significant (p<0.05) over-expressed terms
associated with the up- and downregulated genes were
found in both strains subjected to CMS. Functional annota-
tion was done in each strain on a list of up- and down-
regulated transcripts separately. In HA mice, CMS affected
the upregulation of genes involved in, e.g., intracellular
signaling, ion binding, neuropeptide hormone activity,
and metabolism of cAMP and nucleotides (Fig. 4a).
Downregulated genes were those involved in ion trans-
port, reproductive and mating behavior, neuron differen-
tiation and dendrite development, cell communication,
regulation of insulin secretion and response to insulin
stimulus, regulation of transport, homeostasis, focal ad-
hesion, ion channel activity, or MAPK signaling pathway
(Fig. 4b).
In LA mice, CMS affected the upregulation of genes
involved in the activation of protein kinase C, regulation
of transcription, calcium ion binding, hormone binding,
or coding elements of dendrites (Fig. 5a). Downregu-
lated genes were involved in locomotory behavior, signal
transduction and immunity processes, or long-term depression
(Fig. 5b).
For more detailed data interpretation, we performed
the functional clustering of DEGs. Functional clustering
of DEGs between stressed vs. control animals revealed
several functional groups of genes in each strain. Alto-
gether, 11 main clusters were found for HA (Table 8)
and 12 for LA (Table 9). Specific clusters for HA strain
contain genes involved in regulation of hormone secre-
tion/regulation of insulin secretion, ion binding, regula-
tion of primary metabolic process/regulation of cAMP
biosynthetic process, and cell junction/adherens junction.
Specific clusters for LA strain contain genes involved in
response to stress, dendrite/neuron projection, immune
effector process/immune response, intracellular signaling
cascade/GTPase regulator activity and cognition. Func-
tional clustering revealed similar clusters in both lines
despite containing different genes. Overlapping clusters
in both strains were clusters such as signal transduction,
response to stimulus, regulation of biological quality
and homeostasis, cell differentiation, apoptosis and cell
death, regulation of transcription and gene expression,
and signal transducer/receptor activity. Clusters were
identified in the list of the significantly upregulated
and downregulated genes in non stressed vs. stressed
animals. Tables 8 and 9 present significant functional
clusters with differentially expressed genes and their
expression values.
Validation of Microarrays
To confirm differential expression indicated by the micro-
array expression patterns, the quantitative real-time re-
verse transcription PCR was used (qPCR). qPCR were
performed using aliquots of the non-pooled total RNA.
Following genes were selected from the list of the
significant functional clusters in each strain: Ttr, Drd1,
Dgkg, Prkcb, VGluT1, Prlr, and Nts for HA strain, and
Table 4 Upregulated genes
associated with the gene ontolo-
gy (GO) biological process
terms (p<0.05) in the prefrontal
cortex of low analgesia (LA)
mice
GO biological process Number of genes EASE score Genes
Neuron differentiation 4 0.046 SEMA5A, EXOC7, PCSK9, RPGRIP1
Response to stimulus 10 0.048 CRHR1, BAT5, ERCC5, S100A8, CAMP,
S100A9, PCSK9, MPO, RPGRIP1, PSMB9
Generation of neurons 4 0.049 SEMA5A, EXOC7, PCSK9, RPGRIP1
Table 5 Upregulated genes associated with the gene ontology (GO) molecular function terms (p<0.05) in the prefrontal cortex of low analgesia
(LA) mice
GO molecular function Number of genes EASE score Genes
Structural constituent of ribosome 3 0.033 MRPS18C, RPL6, RPS15A
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Ttr, Crhr1, Dgke, Grm5, Prkcc, Gpm6a, and Mog for
LA strain. The expression patterns of the selected genes
are shown in Fig. 6a, b. Similar trends in gene expres-
sion were shown as in the microarrays. Genes selected
according to microarray analyses showed corresponding
values with a high correlation. Correlation for the selected
data points was R00.91 (p<0.0001).
Discussion
Environmental factors and genes contribute to the man-
ifestation of phenotype which, however, may occur or
not. The proper activity of a complex organ such as the
brain relies on precise temporal and spatial gene expres-
sion patterns. The phenotype is a result of a cascade of
transcriptional events that finally triggers gene expres-
sion and determines the function of the particular brain
structures. While a certain set of genes is constantly
expressed to maintain the organ structure, a varying
number of genes are regulated according to the meta-
bolic demand of the surrounding organism. PFC is the
brain region that is most sensitive to the detrimental
effects of stress exposure. Abilities of PFC depend on
proper neuronal network connections, which are highly
sensitive to their neurochemical environment (Arnsten
2009). Since exposure to even a mild uncontrollable
stress can rapidly impair PFC functions, which contrib-
ute to PFC deficits and structural changes in human and
animals, a good understanding of the genetic control of
chronic stress exposure will facilitate further progress in
understanding the pathophysiology of stress. Gene ex-
pression level could thus be a biomarker and provide
information, for example, for psychiatric diagnosis.
It is important to have animal models of stress response
to understand the mechanisms that render individuals vul-
nerable. In this study, we have focused on the comparison of
prefrontal cortex transcription profiles between naive and
stressed inbred mice strains with different sensitivity to
stress. Studies of differences in gene expression were
carried out with 24 K oligonucleotide microarrays for
genome-wide gene expression analysis and the real-time
RT-PCR technique for microarray validation. To deter-
mine the physiological processes that are differentially
Table 6 Common transcripts with overlapping changes in the prefrontal cortex of high (HA) and low (LA) analgesia mice followed chronic mild
stress (CMS)
Gene symbol Definition Expression HA fold change LA fold change
Ttr Transthyretin (Ttr) ↑ 6.09 2.54
Tomm22 Translocase of outer mitochondrial membrane 22 ↑↓ 2.75 −2.18
C1ql2 Complement component 1, q subcomponent-like 2 ↑ 1.32 1.48
1300006M19Rik RIKEN cDNA 1300006 M19 gene ↑ 2.26 2.38
0610009K11Rik Mitochondrial ubiquitin ligase activator of NFKB 1 ↑↓ 2.12 −1.58
Wdr6 WD repeat domain 6 (Wdr6) ↑ 1.97 1.56
Mtss1l Metastasis suppressor 1-like ↑ 1.45 1.55
BC040774 ↑ 2.46 2.20
BC060632 ↑ 1.86 1.65
Nell2 Nel-like 2 homolog (chicken) (Nell2) ↑ 1.54 2.29
Calb2 calbindin 2 (Calb2) ↑ 1.69 1.29
Rab5b RAB5B, member RAS oncogene family (Rab5b) ↑ 1.58 2.36
Krt1-12 Keratin complex 1, acidic, gene 12 (Krt1-12) ↑↓ 1.61 −1.37
Nnat Neuronatin (Nnat), transcript variant 2 ↑ 1.50 1.83
Dgkg Diacylglycerol kinase, gamma (Dgkg) ↑ 1.30 1.25
C630041L24Rik RIKEN cDNA C630041L24 gene ↑ 1.28 1.35
Cntnap4 Contactin-associated protein 4 (Cntnap4) ↑ 0.52 0.75
Ddx6 DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 ↓ −1.38 −1.46
AI593442 Mus musculus expressed sequence AI593442 ↓ −1.51 −1.68
Rasd2 RASD family, member 2 ↓ −1.73 −1.64
Indo Indoleamine-pyrrole 2,3 dioxygenase ↓ −2.19 −1.89
Rgs9 Regulator of G-protein signaling 9 (Rgs9) ↓ −2.35 −2.31
Pigt Phosphatidylinositol glycan, class T (Pigt) ↓ −3.22 −1.25
“↑” upregulation, “↓” downregulation
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regulated between strains, the DAVID 6.7 Functional
Annotation Tool was used.
For validation of oligonucleotide chip data, we per-
formed real-time RT-PCR with the same RNA samples that
was used for the microarray experiments. Gapdh and Hprt1
were used as a reference. These genes were not regulated
between HA and LA during stress procedure in our study
and have been used successfully as a housekeeping control
in previous study as well (Lisowski et al. 2011). Other
housekeeping genes that have been proposed such as beta
actin were found to be regulated in brain between strains
and/or stressed vs. control mice. In this study, the average
fold change of correlation between microarray and qRT-
PCR was 0.91 (p<0.0001). Large-scale study of real-time
RT-PCR and gene expression measurements with commer-
cial oligonucleotide microarrays concluded that microarrays
are invaluable discovery tools with acceptable reliability for
genome-wide gene expression screening, though validation
of putative changes in gene expression remains advisable
(Wang et al. 2006).
Differences in Basal Gene Expression of HA Mice
Compared to LA Mice
As a way of identifying stress-responsive candidate genes,
we conducted gene expression profiling studies in the PFC
of high (HA) and low (LA) swim stress-induced analgesia
inbred mouse strains. The strains display robust differences
in behavioral tests reflecting depression and in responses to
different classes of antidepressants (desipramine, venlafax-
ine, and aminosenktide) (Błaszczyk et al. 2000; Juszczak et
al. 2008a, b, 2006; Panocka et al. 1986a). Experimental
models of SIA help in identifying the fundamental mecha-
nisms of stress response. The phenomenon that pain can be
naturally suppressed leads to speculation that manipulation
of the mechanisms of SIA could be a potential therapeutic
target for stress- and anxiety-related disorders (Butler and
Finn 2009). It may also be possible to utilize the expression
of SIA as a predictor for development of psychological
disorders (Meeus et al. 2008; Nishith et al. 2002; Pielsticker
et al. 2005; Staud et al. 2003).
Identification of 193 differentially expressed genes be-
tween the strains supported by functional classification
showed that selective breeding seriously affected frontal
cortex development in aspect of structural changes such as
neuron projection, neuron development, neuron differentia-
tion, membrane organization, or dendrite development. SIA
is mediated by activation of the descending inhibitory pain
pathway that originates in neurons in higher brain regions
such as the cortex. Neurons in the cortex also relay noci-
ceptive information to the amygdala, hypothalamus, or di-
rectly to the periaqueductal grey. The PFC has also been
implicated in the recall and extinction of fear-related mem-
ory of noxious stimuli (Hugues et al. 2004). Upregulation in
the PFC of HA mice expression pattern of genes involved in
calcium ion binding, lipid binding, diacyroglicerol binding,
VEGF signaling, MAPK signaling, T cell receptor signaling,
focal adhesion, or long-term potentiation suggests increased
activation of neurons, leading to high analgesic phenotype
and complex prefrontal cortex mechanisms of pain, stress,
or fear.
Effects of Chronic Mild Stress on Gene Expression in HA
and LA Mice
The chronic mild stress has been studied at the cellular level
(Airan et al. 2007; Banasr and Duman 2007; Garcia-Garcia
et al. 2009; Gronli et al. 2007; Jayatissa et al. 2008; Warner-
Schmidt and Duman 2006). In addition to core symptoms of
depression, such as long-lasting anhedonia (Elizalde et al.
2008), CMS induces neuroadaptive changes that could be
addressing clinical findings with depressed patients (Frodl et
al. 2008; Gould et al. 2007; Lucassen et al. 2006; Rajkowska
2000; Sanacora et al. 2004). Very little is known about the
Table 7 Clusters of overlapping transcripts determined by the DAVID
v6.7 software (p<0.05)
Gene symbol Definition
Signal transduction/intracellular signaling cascade
Rab5b RAB5B, member RAS oncogene family
Rasd2 RASD family, member 2
Cntnap4 Contactin-associated protein-like 4
Dgkg Diacylglycerol kinase, gamma
Mtss1l Metastasis suppressor 1-like
Rgs9 Regulator of G-protein signaling 9
Calcium ion binding/metal ion binding/cation binding
Nell2 NEL-like 2 (chicken)
Calb2 Calbindin 2
Dgkg Diacylglycerol kinase, gamma
Transport/establishment of localization
Rab5b RAB5B, member RAS oncogene family




Rab5b RAB5B, member RAS oncogene family
Rasd2 RASD family, member 2
Calb2 Calbindin 2
Cntnap4 Contactin-associated protein-like 4
AI593442 Expressed sequence AI593442
Pigt Phosphatidylinositol glycan anchor
biosynthesis
Tomm22 Translocase of outer mitochondrial
membrane 22 homolog
Rgs9 Regulator of G-protein signaling 9
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effects of chronic stress on transcriptome in the prefrontal
cortex. Recent studies on primates demonstrate that social
stress reduces the expression of many genes in the PFC that
are involved in synaptic plasticity, cell cycle progression, and
nuclear receptor signaling (Karssen et al. 2007). According to
Tordera (2011), CMS affected the regulation of 147 transcripts
in a mouse CMSmodel, some of them involved in response to
stress and oxidoreductase activity. Here, we aimed to identify
in animals with different genetic background (HA CMS and
LACMSmice) specific gene expression profiles and common
Fig. 4 Significantly enriched (p<0.05) gene ontology (GO) categories
of genes affected by chronic mild stress (CMS) in the prefrontal cortex
of high analgesia (HA) mice: a upregulated transcripts, and b
downregulated transcripts. GO categories shown in the figure consists
of biological processes, molecular functions, cellular components, and
biochemical pathways
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gene expression changes. We have identified genes similarly
regulated by CMS in both strains. Overlapping genes with the
same expression pattern in both mouse models are involved in
coding elements of cell membrane part and are involved in
signal transduction, calcium ion binding, and transport. We
observed robust upregulation of Ttr gene coding transthyretin
(TTR). Transthyretin is one of the three prealbumins: alpha-1-
antitrypsin, transthyretin, and orosomucoid. Transthyretin is a
carrier protein and a major transporter of thyroid hormones
and retinol in the plasma and cerebrospinal fluid (Landers et
al. 2009). The diseases caused by mutations in TTR include
amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia,
amyloidotic vitreous opacities, cardiomyopathy, oculolepto-
meningeal amyloidosis, meningocerebrovascular amyloid-
osis, or carpal tunnel syndrome (Blevins et al. 2003; Garzuly
et al. 1996; Jones et al. 1992; Murakami et al. 1994, 1992;
Saraiva et al. 1992). Clinical features of defects in TTR include
seizures, stroke-like episodes, dementia, and psychomotor
Fig. 5 Significantly enriched (p<0.05) gene ontology (GO) categories
of genes affected by chronic mild stress (CMS) in the prefrontal cortex
of low analgesia (LA) mice: a upregulated transcripts, and b
downregulated transcripts. GO categories shown in the figure consists
of biological processes, molecular functions, cellular components and
biochemical pathways
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Table 8 Clusters of genes determined by the DAVID v6.7 software (p<0.05) affected by chronic mild stress (CMS) in the prefrontal cortex of high
analgesia (HA) mice
Gene symboal Gene name Expression Fold Change
Regulation of cell communication/regulation of signal transduction
Bat2 HLA-B-associated transcript 2 ↑ 1.48
Acvr1c Activin A receptor, type IC ↓ −2.10
Bai1 Brain-specific angiogenesis inhibitor 1 ↑ 1.61
Dkk3 Dickkopf homolog 3 (Xenopus laevis) ↓ −1.48
Drd1a Dopamine receptor D1A ↓ −1.28
Mtap1b Microtubule-associated protein 1B ↓ −1.45
Palm Paralemmin ↑ 1.34
Cbx3 Predicted gene 6917; similar to chromobox homolog 3 ↓ −2.17
Rgs9 Regulator of G-protein signaling 9 ↓ −2.35
Sostdc1 Sclerostin domain containing 1 ↑ 1.50
Srp9 Signal recognition particle 9 ↑ 2.49
Timp2 Tissue inhibitor of metalloproteinase 2 ↑ 1.55
Regulation of hormone secretion/regulation of insulin secretion
Bat2 HLA-B-associated transcript 2 ↑ 1.48
Acvr1c Activin A receptor, type IC ↓ −2.10
Avp Arginine vasopressin ↑ 3.67
Drd1a Dopamine receptor D1A ↓ −1.28
Il12a Interleukin 12a ↓ −1.32
Kl Klotho ↓ −2.20
Nnat Neuronatin ↑ 1.50
Pfkm Phosphofructokinase, muscle ↓ −1.83
Ion binding
Arl3 ADP-ribosylation factor-like 3 ↑ 3.10
Lasp1 LIM and SH3 protein 1 ↓ −1.85
Nell2 NEL-like 2 (chicken) ↑ 1.70
Acvr1c Activin A receptor, type IC ↓ −2.10
Calb2 Calbindin 2 ↑ 1.69
Cacna2d1 Calcium channel, voltage-dependent, alpha2/delta subunit 1 ↓ −1.38
Calml4 Calmodulin-like 4 ↑ 1.52
Clic6 Chloride intracellular channel 6 ↑ 1.77
Dgkg Diacylglycerol kinase, gamma ↑ 1.30
Hpcal4 Hippocalcin-like 4 ↑ 1.22
Kl Klotho ↑ 1.92
Mmp17 Matrix metallopeptidase 17 ↓ −1.26
Myl4 Myosin, light polypeptide 4 ↓ −1.50
Pfkm Phosphofructokinase, muscle ↓ −1.83
Kcnb1 Potassium voltage gated channel, Shab-related subfamily ↓ −1.98
Kcnh1 Potassium voltage-gated channel, subfamily H (eag-related) ↓ −1.85
Pnck Pregnancy upregulated non-ubiquitously expressed CaM kinase ↑ 1.40
Prkcb Protein kinase C, beta ↓ −0.65
Sparc Secreted acidic cysteine rich glycoprotein ↑ 1.54
Slc17a7 Solute carrier family 17 ↑ 1.22
Zfp423 Zinc finger protein 423; similar to mKIAA0760 protein ↑ 1.42
Zcchc12 Zinc finger, CCHC domain containing 12 ↑ 1.89
Regulation of primary metabolic process/regulation of cAMP biosynthetic process
Avp Arginine vasopressin ↑ 3.67
Drd1a Dopamine receptor D1A ↓ −1.28
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Table 8 (continued)
Gene symboal Gene name Expression Fold Change
Palm Paralemmin ↑ 1.34
Kcnh1 Potassium voltage-gated channel, subfamily H ↓ −1.85
Cbx3 Predicted gene 6917; similar to chromobox homolog 3 ↓ −2.17
Rbbp4 Retinoblastoma binding protein 4 ↓ −1.87
Srp9 Signal recognition particle 9 ↑ 2.49
Timp2 Tissue inhibitor of metalloproteinase 2 ↑ 1.55
Zfp423 Zinc finger protein 423; similar to mKIAA0760 protein ↑ 1.42
Zcchc12 Zinc finger, CCHC domain containing 12 ↑ 1.89
Cell junction/adherens junction
Lasp1 LIM and SH3 protein 1 ↓ −1.85
Calb2 Calbindin 2 ↑ 1.69
Cbln1 Cerebellin 1 precursor protein; similar to precerebellin-1 ↓ −2.06
Pak1 p21 protein (Cdc42/Rac)-activated kinase 1 ↓ −2.06
Pkp2 Plakophilin 2 ↑ 1.26
Slc17a7 Solute carrier family 17 ↑ 1.22
Response to endogenous stimulus/response to hormone stimulus
Bat2 HLA-B-associated transcript 2 ↑ 1.48
Bat5 HLA-B-associated transcript 5 ↑ 3.36
Rasd2 RASD family, member 2 ↓ −1.73
Acvr1c Activin A receptor, type IC ↓ −2.10
Avp Arginine vasopressin ↑ 3.67
Drd1a Dopamine receptor D1A ↓ −1.28
H2-L Histocompatibility 2, D region; histocompatibility 2 ↑ 2.56
Il12a Interleukin 12a ↓ −1.32
Nnat Neuronatin ↑ 1.50
Ppp1r1b Protein phosphatase 1, regulatory (inhibitor) subunit 1B ↓ −1.68
Ptpra Protein tyrosine phosphatase, receptor type, A ↓ −1.78
Rgs9 Regulator of G-protein signaling 9 ↓ −2.35
Slc17a7 Solute carrier family 17 ↑ 1.22
Trh Thyrotropin-releasing hormone ↑ 1.91
Homeostatic process/regulation of biological quality
Avp Arginine vasopressin ↑ 3.67
Drd1a Dopamine receptor D1A ↓ −1.28
Nts Neurotensin ↑ 1.58
Palm Paralemmin ↑ 1.34
Pfkm Phosphofructokinase, muscle ↓ −1.83
Prkcb Protein kinase C, beta ↓ −0.65
Ppp1r1b Protein phosphatase 1, regulatory (inhibitor) subunit 1B ↓ −1.68
Slc17a7 Solute carrier family 17 ↑ 1.22
Generation of neurons/neurogenesis/neuron differentiation
Acvr1c Activin A receptor, type IC ↓ −2.10
Dkk3 Dickkopf homolog 3 (Xenopus laevis) ↓ −1.48
Drd1a Dopamine receptor D1A ↓ −1.28
Kl Klotho ↑ 1.92
Mtap1b Microtubule-associated protein 1B ↓ −1.45
Nnat Neuronatin ↑ 1.50
Pak1 p21 protein (Cdc42/Rac)-activated kinase 1 ↓ −2.06
Pigt Phosphatidylinositol glycan anchor biosynthesis, class T ↓ −3.22
Pkp2 Plakophilin 2 ↑ 1.26
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deterioration. The absence of TTR protein in TTR-null mice is
associated with increased exploratory activity and reduced
depression-like behavior (Sousa et al. 2004). Cell cultures
incubated with TTR oligomers were proven to induce
cytotoxicity by Ca2+ efflux from the endoplasmic retic-
ulum (Teixeira et al. 2006). Moreover, recent observation
conducted by Andrus (2012) classified Ttr to the set of genes
whose hippocampal or amygdalar expression patterns were
altered by chronic stress in four rat strains represent a gener-
alizable molecular response to chronic stress. Taken together,
we observed stress-associated significant cortical upregulation
of Ttr and calcium ion binding genes (Nell2, Calb2, Dgkg) in
both high and low analgesia mouse strains.
Given the genetic heterogeneity, it is likely that not all the
subjects will show identical changes in all genes. We found
that an individual's genetic make-up does make a serious
difference in how the individual, at the gene expression
level, responds to stress. Functional clustering revealed sev-
en statistically significant overlapping groups of differen-
tially expressed genes between control and stressed animals.
Common clusters, in both strains, included genes involved
in behavior, signal transduction, response to hormone stim-
ulus, homeostasis, neuron differentiation, neurogenesis, and
apoptosis. The HA strain-specific groups of genes were
involved in regulation of insulin secretion, cAMP biosyn-
thetic process and cell junction. The LA strain groups of
genes were connected with response to stress, dendrite and
neuron projection, immune response, GTP-ase activity, and
cognition.
Exposure to chronic stress leads to extensive alterations
in the architecture of PFC including loss of dendritic mate-
rial (Brown et al. 2005). Whereas structural changes in the
hippocampus require several weeks of stress exposure, den-
drites in the PFC begin to change after 1 week of stress or
possibly even a single exposure (Brown et al. 2005;
Izquierdo et al. 2006; McEwen 2004). The signaling mech-
anisms that underlie these changes in the PFC are just
beginning to be studied. Each member of the PKC family
has a specific expression profile and is believed to play
distinct roles in cells. Protein kinase C gamma type is
Table 8 (continued)
Gene symboal Gene name Expression Fold Change
Prlr Prolactin receptor ↑ 1.62
Sostdc1 Sclerostin domain containing 1 ↑ 1.50
Timp2 Tissue inhibitor of metalloproteinase 2 ↑ 1.55
Zfp423 Zinc finger protein 423; similar to mKIAA0760 protein ↑ 1.42
Apoptosis/cell death
Bat2 HLA-B-associated transcript 2 ↑ 1.48
Acvr1c Activin A receptor, type IC ↓ −2.10
Pigt Phosphatidylinositol glycan anchor biosynthesis, class T ↓ −3.22
Regulation of gene expression/regulation of transcription
Kcnh1 Potassium voltage-gated channel, subfamily H ↓ −1.85
Cbx3 Predicted gene 6917; similar to chromobox homolog 3 ↓ −2.17
Rbbp4 Retinoblastoma binding protein 4 ↓ −1.87
Srp9 Signal recognition particle 9 ↑ 2.49
Zfp423 Zinc finger protein 423; similar to mKIAA0760 protein ↑ 1.42
Zcchc12 Zinc finger, CCHC domain containing 12 ↑ 1.89
Signal transducer activity/receptor activity
Acvr1c Activin A receptor, type IC ↓ −2.10
Bai1 Brain-specific angiogenesis inhibitor 1 ↑ 1.61
Drd1a Dopamine receptor D1A ↓ −1.28
Folr1 Folate receptor 1 (adult) ↑ 1.23
Igsf1 Immunoglobulin superfamily, member 1 ↑ 2.09
Kcnh1 Potassium voltage-gated channel, subfamily H ↓ −1.85
Tomm22 Predicted gene 12906; predicted gene 7250 ↑ 2.75
Prlr Prolactin receptor ↑ 1.62
Ptpra Protein tyrosine phosphatase, receptor type, A ↓ −1.78
Rgs9 Regulator of G-protein signaling 9 ↓ −2.35
“↑” upregulation, “↓” downregulation
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Table 9 Clusters of genes determined by the DAVID v6.7 software (p<0.05) affected by chronic mild stress (CMS) in the prefrontal cortex of low
analgesia (LA) mice
Gene symbol Gene name Expression Fold change
Signal transduction
Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide ↓ −2.66
Gpr88 G-protein coupled receptor 88 ↓ −1.23
Rab5b RAB5B, member RAS oncogene family ↑ 2.36
Rasgrp1 RAS guanyl-releasing protein 1 ↑ 1.31
Rasd2 RASD family, member 2 ↓ −1.64
Cntnap4 Contactin-associated protein-like 4 ↑ 0.75
Crhr1 Corticotropin-releasing hormone receptor 1 ↓ −1.76
Dgke Diacylglycerol kinase, epsilon ↑ 1.66
Dgkg Diacylglycerol kinase, gamma ↑ 1.25
Grm5 Glutamate receptor, metabotropic 5 ↓ −0.95
Gdi1 Guanosine diphosphate (GDP) dissociation inhibitor 1 ↑ 1.99
Matk Megakaryocyte-associated tyrosine kinase ↓ −1.53
Prkcc Protein kinase C, gamma ↑ 2.54
Rgs9 Regulator of G-protein signaling 9 ↓ −2.31
Spock2 Sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 ↑ 1.44
Response to stress
Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide ↓ −2.66
Rasd2 RASD family, member 2 ↓ −1.64
S100a8 S100 calcium binding protein A8 (calgranulin A) ↓ −3.78
S100a9 S100 calcium binding protein A9 (calgranulin B) ↓ −3.32
Capn2 Calpain 2 ↑ 3.76
Camp Cathelicidin antimicrobial peptide ↓ −1.72
Crhr1 Corticotrophin-releasing hormone receptor 1 ↓ −1.76
Grm5 Glutamate receptor, metabotropic 5 ↓ −0.95
Mt3 Metallothionein 3 ↑ 1.89
Mpo Myeloperoxidase ↓ −1.85
Nnat Neuronatin ↑ 1.83
Igh-VJ558 Predicted gene 5353; immunoglobulin heavy chain (J558 family) ↓ −1.63
Prkcc Protein kinase C, gamma ↑ 2.54
Rgs9 Regulator of G-protein signaling 9 ↓ −2.31
Dendrite/neuron projection
Crmp1 Collapsin response mediator protein 1 ↑ 1.36
Cntnap4 Contactin-associated protein-like 4 ↑ 0.75
Prkcc Protein kinase C, gamma ↑ 2.54
Immune effector process/immune response
Atp6v0a1 ATPase, H + transporting, lysosomal V0 subunit A1 ↑ 1.62
Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide ↓ −2.66
S100a9 S100 calcium binding protein A9 (calgranulin B) ↓ −3.32
Mpo Myeloperoxidase ↓ −1.85
Igh-VJ558 Predicted gene 5353; immunoglobulin heavy chain (J558 family) ↓ −1.63
Intracellular signaling cascade/GTPase regulator activity
Rab5b RAB5B, member RAS oncogene family ↑ 2.36
Rasgrp1 RAS guanyl-releasing protein 1 ↑ 1.31
Rasd2 RASD family, member 2 ↓ −1.64
Dgke Diacylglycerol kinase, epsilon ↑ 1.66
Dgkg Diacylglycerol kinase, gamma ↑ 1.25
Gdi1 Guanosine diphosphate (GDP) dissociation inhibitor 1 ↑ 1.99
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Table 9 (continued)
Gene symbol Gene name Expression Fold change
Prkcc Protein kinase C, gamma ↑ 2.54
Rgs9 Regulator of G-protein signaling 9 ↓ −2.31
Behavior/response to external stimulus
Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide ↓ −2.66
Rasd2 RASD family, member 2 ↓ −1.64
S100a8 S100 calcium binding protein A8 (calgranulin A) ↓ −3.78
S100a9 S100 calcium binding protein A9 (calgranulin B) ↓ −3.32
Crhr1 Corticotrophin-releasing hormone receptor 1 ↓ −1.76
Grm5 Glutamate receptor, metabotropic 5 ↓ −0.95
Prkcc Protein kinase C, gamma ↑ 2.54
Ion homeostasis/regulation of biological quality
Crym Crystallin, mu ↑ 1.85
Grm5 Glutamate receptor, metabotropic 5 ↓ −0.95
Ltf Lactotransferrin ↓ −2.59
Mt3 Metallothionein 3 ↑ 1.89
Sepw1 Selenoprotein W, muscle 1 ↑ 1.39
Slc26a4 Solute carrier family 26, member 4 ↑ 1.32
Nervous system development/cell differentiation
Atp6v0a1 ATPase, H + transporting, lysosomal V0 subunit A1 ↑ 1.62
Capn2 Calpain 2 ↑ 3.76
Grm5 Glutamate receptor, metabotropic 5 ↓ −0.95
Kif3a Kinesin family member 3A ↓ −1.97
Lbh Limb-bud and heart ↑ 1.50
Mt3 Metallothionein 3 ↑ 1.89
Mog Myelin oligodendrocyte glycoprotein ↑ 1.37
Nnat Neuronatin ↑ 1.83
Nfib Nuclear factor I/B ↑ 1.37
Pigt Phosphatidylinositol glycan anchor biosynthesis, class T ↓ −1.25
Prkcc Protein kinase C, gamma ↑ 2.54
Rgs9 Regulator of G-protein signaling 9 ↓ −2.31
Slc26a4 Solute carrier family 26, member 4 ↑ 1.32
Thra Thyroid hormone receptor alpha; similar to thyroid hormone receptor ↑ 1.31
Regulation of apoptosis/regulation of programmed cell death
Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide ↓ −2.66
Eef1a2 Eukaryotic translation elongation factor 1 alpha 2 ↑ 1.90
Mal Myelin and lymphocyte protein, T-cell differentiation protein ↑ 1.37
Regulation of transcription/regulation of gene expression
Atp6v0a1 ATPase, H + transporting, lysosomal V0 subunit A1 ↑ 1.62
Atf4 Activating transcription factor 4 ↑ 1.45
Brms1l Breast cancer metastasis-suppressor 1-like ↑ 1.33
Eef1a2 Eukaryotic translation elongation factor 1 alpha 2 ↑ 1.90
Lbh Limb-bud and heart ↑ 1.50
Nfib Nuclear factor I/B ↑ 1.37
Thra Thyroid hormone receptor alpha; similar to thyroid hormone receptor ↑ 1.31
Zfp238 Zinc finger protein 238 ↑ 1.81
Signal transducer activity/receptor activity/G-protein coupled receptor activity
Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide ↓ −2.66
Gpr88 G-protein coupled receptor 88 ↓ −1.23
Crhr1 Corticotrophin-releasing hormone receptor 1 ↓ −1.76
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expressed solely in the brain and spinal cord and its local-
ization is restricted to neurons. It has been demonstrated that
several neuronal functions, including long-term potentiation
(LTP) and long-term depression, specifically require this
kinase. Knockout studies in mice also suggest that this
kinase may be involved in neuropathic pain development
(Malmberg et al. 1997). In our study, we have found that
CMS decreased transcription of protein kinase C, beta
(Prkcc) in HA mice and increased protein kinase C, gamma
(Prkcg) in LA. Glucocorticoid release during stress could
potentiate stress-signaling pathways through activation of
PKC signaling (Han et al. 2002).
Chronic stress alters catecholamine pathways increasing
noradrenergic innervation of the PFC although dopamine
becomes depleted with severe chronic stress (Miner et al.
2006; Mizoguchi et al. 2000). Increased noradrenaline
might lead to higher levels of PKC and cAMP signaling
(Arnsten 2009). In LA mice, we have identified a cluster of
genes downregulated by CMS which are involved in the
cAMP biosynthetic process including the dopamine receptor
D1A (Drd1a). Moreover, PKCs require Ca2+, diacylglycerol
(DAG), and a phospholipid such as phosphatidylserine for
activation. According to this, another interesting group of
genes identified in LA mice was intracellular signaling
cascade/GTP-ase regulator activity cluster. This cluster, be-
sides Prkcg consist of several upregulated genes in LA CMS
animals including diacylglycerol kinases epsilon (Dgke) and
gamma (Dgkg) involved in PKC signaling.
Stress-induced changes in dendritic morphology may be
associated with upregulation of another two genes consti-
tuting dendrite/neurite projection gene cluster such as
Crmp1 (collapsin response mediator protein 1) and Cntnap4
(contactin associated protein-like 4). Crmp1 encodes a
member of a family of cytosolic phosphoproteins expressed
exclusively in the nervous system. Encoded protein is
thought to be a part of the semaphorin signal transduction
pathway implicated in semaphorin-induced growth cone
collapse. CRMP1 is necessary for signaling by class 3
semaphorins and subsequent remodeling of the cytoskele-
ton. Furthermore, it plays a role in axon guidance while
Cntnap4 product belongs to the neurexin family, members
of which function in the nervous system as cell adhesion
molecules and receptors (Pasterkamp and Giger 2009;
Yamashita et al. 2007).
Neural remodeling is a fundamental process by which the
brain responds to environmental influences during stress. In
PFC of stressed LA mice, we identified upregulation of
three stress-responsive genes involved in myelin function:
Gpm6a, Mal, and Mog. Gpm6a codes glycoprotein M6a
which plays an important role in neurite outgrowth and
synapse formation (Alfonso et al. 2005). This gene is down-
regulated in the hippocampus of both socially and physical-
ly stressed animals, and this effect can be reversed by
antidepressant treatment (Alfonso et al. 2005). In our previ-
ous study, we found downregulation of Gpm6a in hippo-
campus of LA mice after CMS (Lisowski et al. 2011).
GMP6A may play a role in the stress-induced hippocampal
alterations that are found in psychiatric disorders (Boks et al.
2008). Mal encodes integral membrane protein belonging to
the MAL family of proteolipids involved in myelin biogen-
esis and function. The product of Mog is a membrane
protein MOG, expressed on the oligodendrocyte cell surface
and the outermost surface of myelin sheaths. Downregula-
tion of cortical Mog expression was found to be involved in
schizophrenia and major depressive disorder (Aston et al.
2005; Martins-de-Souza et al. 2010). In the other hand,
MOG is detectable in multiple sclerosis (MS) patients and
is suspected to be involved in pathogenesis of MS (Stern
and Keskin 2008). Upregulation of genes that encode struc-
tural components of myelin such as Gpma6, Mal, and Mog
in PFC of LA mice could be an adaptive mechanism of
stress response dependent on stress procedure duration or
individual vulnerability.
CMS induces neuroadaptive changes that could address
clinical findings in depressed patients (Frodl et al. 2008;
Gould et al. 2007; Lucassen et al. 2006; Rajkowska 2000;
Table 9 (continued)
Gene symbol Gene name Expression Fold change
Grm5 Glutamate receptor, metabotropic 5 ↓ −0.95
Mog Myelin oligodendrocyte glycoprotein ↑ 1.37
Tomm22 Predicted gene 12906; predicted gene 7250 ↓ −2.18
Rgs9 Regulator of G-protein signaling 9 ↓ −2.31
Thra Thyroid hormone receptor alpha; similar to thyroid hormone receptor ↑ 1.31
Cognition
Grm5 Glutamate receptor, metabotropic 5 ↓ −0.95
Prkcc Protein kinase C, gamma ↑ 2.54
Rgs9 Regulator of G-protein signaling 9 ↓ −2.31
“↑” upregulation, “↓” downregulation
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Sanacora et al. 2004). Recent clinical (Uezato et al. 2009)
and preclinical studies (Garcia-Garcia et al. 2009; Tordera et
al. 2007) have linked decreased levels of the synaptic ves-
icle protein vesicular glutamate transporter 1 (VGLUT1) to
depressive-like behavior. In addition, recent studies with
heterozygous VGLUT1 knockout mice suggest that de-
creased VGLUT1 levels affects glutamate transmission
and induces depressive-like behavior comorbid with anxiety
and impaired recognition memory (Balschun et al. 2010;
Tordera et al. 2007). On the other hand, in our study, we
noticed upregulation of VGluT1 (also Slc17a7) in HA CMS
mice and downregulation of metabotropic glutamate recep-
tor 5 (Grm5) in LA CMS mice. Grm5 is a subtype of group I
glutamate receptors, is highly expressed in limbic forebrain
regions, and is thought to modulate anxiety-related process-
es. The blockade of Grm5 by specific antagonist 2-methyl-
6-(phenylethynyl) pyridine, reduce extracellular norepi-
nephrine, the impact of which may contribute to their anxi-
olytic actions (Page et al. 2005). We suggest that the
downregulation of Grm5 together with disregulation of other
genes included in signal transduction and response to stress






























































Fig. 6 Validation of expression of the selected genes by qPCR: a HA
control vs. HA followed by CMS; b LA control vs. LA followed by
CMS. Results are presented as means of relative mRNA levels in 15
individuals per experimental group; error indicators show ± S.E.M.
Values differ significantly at * p<0.05, ** p<0.01 or *** p<0.001;
qPCR values were normalized to geometric mean of the raw expression
data of two reference genes: Gapdh and Hprt1. Abbreviations: qPCR,
quantitative real-time RT-PCR; HA, high analgesia mice; LA, low
analgesia mice; CMS, chronic mild stress; S.E.M., standard error of
measurement or mean; Gapdh, glyceraldehyde-3-phosphate dehydro-
genase; Hprt1, hypoxanthine phosphoribosyltransferase 1
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be a mechanism of adaptation to stress of stress resistant
individuals. Moreover, upregulation of VGluT1 is according
to our previous study in which we have observed significant
upregulation of VGluT1 and VGluT2mRNA in the hippocam-
pus of LA mice after CMS procedure (Lisowski et al. 2011).
In HA mice, we observed significant upregulation of
arginine vasopressin transcript (Avp). Activation of the
hypothalamic-pituitary-adrenal system by psychosocial
stress is accompanied by an increase in peripheral plasma
AVP levels in human study (Zimmermann et al. 2004).
Repeated stress is known to induce an increased vasopressin
(AVP) expression in paraventricular corticotrophin-
releasing hormone (CRH) neurons that is supposed to en-
hance the ACTH-releasing capacity of these cells. Acute
immobilization produced a significant increase in the aver-
age AVP and CRF mRNA levels in the medial parvocellular
subdivisions of the paraventricular nucleus (PVN) (Aubry et
al. 1999). PVN AVP mRNA levels are more sensitive to
glucocorticoid negative feedback than are the levels of CRH
mRNA (Makino et al. 1995). In the brain as a whole, AVP
acts on wide array of neurons. AVP might also modulate
emotional memory and anxiety (Koob 2008). We suggest that
in CMS, a robust increase in PFC of Avp mRNA level is a
mechanism contributing to the maintenance of a HPA re-
sponse after repeated stress. Besides hypothalamus and amyg-
dala, the PFC excitatory actions of AVP released from cortical
neurons may also contribute to the behavioral stress response.
In our previous study, we found that naïve HA mice
display robust upregulation of tridecapeptide neurotensin
(NT) receptor transcript (Nts2r) in hippocampus as com-
pared to naïve LA mice (Lisowski et al. 2012). Recently, it
became evident that NT is involved in responsiveness to
both pain and stressful stimuli, suggesting that this neuro-
transmitter may be involved in the phenomenon of non-
opioid SIA (Dobner 2005). The release of endogenous NT
in response to stress requires the presence of NTS2 to
stimulate corticotropin-releasing factor-induced elevation
of plasma corticosterone (Lafrance et al. 2010). These data
highlight the significance of NTS2 as a novel target for the
treatment of pain and stress-related disorders. In the current
study, we observed significant upregulation of neurotensin
transcript (Nts) in HA mice after CMS procedure. This gene
encodes a common precursor for two peptides, neuromedin
N and neurotensin. Neurotensin is a secreted tridecapeptide,
which is widely distributed throughout the central nervous
system, and may function as a neurotransmitter or a neuro-
modulator. It may be involved in dopamine-associated path-
ophysiological events. Both, Nts and Drd1a were clustered
in group of genes involved in homeostatic process/regula-
tion of biological quality in HA CMS mice. In addition to
the role of NT in the regulation of nociceptive processing,
there is accumulating evidence suggesting that NT is in-
volved in hormonal, neural, and behavioral stress-related
responses. NT turnover is also altered under physiological
stress. Exposure to various stressors, such as immobilization
or cold-water swim, induces an up-regulation of the NT
precursor mRNA in several hypothalamic regions, including
the medial preoptic area and the paraventricular nucleus
(Ceccatelli and Orazzo 1993; Seta et al. 2001). Since there
are also studies that provided the evidence for the involve-
ment of NT in the development of neuropsychiatric disor-
ders, we suggest that the involvement of NT in the
regulation of the hypothalamo–pituitary–adrenal gland axis
during chronic stress should be considered in the context of
vulnerability phenotypes.
Among differentially expressed genes of response to
stress cluster in LA CMS mice, we identified robust upre-
gulation of calpain 2 (Capn2) and downregulation of
corticotrophin-releasing hormone receptor 1 (Crhr1). Cal-
pains are a group of calcium-dependent protease that plays a
significant role in synaptic plasticity, cell motility, and neu-
rodegeneration (Liu et al. 2005; Wu and Lynch 2006).
Calpain-mediated spectrin degradation has been implicated
in dendritic spine changes associated with LTP induc-
tion (Lynch and Baudry 1984; Vanderklish and Bahr
2000; Vanderklish et al. 2000). In addition, calpain
inhibitors block LTP induction in vitro and in vivo
(Denny et al. 1990; Staubli et al. 1988). Despite the quite
well-known physiological role of m-calpain in brain, it is not
clear under which conditions m-calpain could be activated
(Friedrich 2004); however, based on our data, the chronic
stress-dependent upregulation of Capn2 in PFC is possible
in vulnerable phenotypes.
PFC contains “hot spots” of receptors for key stress
mediators such as β1-adrenoceptors (β1R), CRH receptors
(CRHR1, CRHR2), mineralocorticoid, and glucocorticoid
receptors (MR, GR) (Joels and Baram 2009). In LA CMS
mice, we observed downregulation of Crhr1 that encodes a
G-protein-coupled receptor that binds neuropeptides of the
CRH family. Actions of stress-induced CRH release are
mediated primarily through binding to CRHR1 while bind-
ing to CRHR2 exert effects at long timescale and might
function to shut down the stress response (Bale et al.
2000; Coste et al. 2000; Muller et al. 2003). Quantity of
Crhr1 mRNA in rodent PFC in contrast to Crhr2 is high
(Aguilera et al. 2004). Significant downregulation of Crhr1
transcription suggests decreased CRH binding following
chronic stress in PFC. It is likely that transcriptional regu-
latory mechanisms that permit rapid changes in Crhr1 ac-
tivity in PFC are important for adaptation of corticotroph
responsiveness to continuous changes in physiological
demands. In this regard, pituitary Crhr1 mRNA levels de-
crease following glucocorticoid administration and recover
only when circulating glucocorticoids decline below stress
levels (Ochedalski et al. 1998). These findings suggest
that the glucocorticoids contribute to the decrease in
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cortical Crhr1 mRNA during stress. The mechanism
regulating PFC Crhr1 mRNA levels during stress is likely
to involve increased exposure of the cortical corticotroph to
glucocorticoids, CRH and AVP.
Insulin plays a role in the structural responses of the brain
to stressors. Lack of insulin causes a decrease in dentate
gyrus neuron number and leads to increased remodeling of
dendrites of CA3 neurons that is further accelerated by
repeated restraint stress. Stress and hyperglycemia both
increase oxidative stress in the brain and this is likely to
contribute, over time, to impaired neural function in chronic
stress and diabetes. In the present study, we found that in
HA mice, genes involved in hormone secretion including
insulin secretion genes were deregulated. Among them, we
found upregulation of prolactin receptor (Prlr). Study
showed that prolactin (PRL) is a neuromodulator of behav-
ioral and neuroendocrine stress coping in the rat (Blume et
al. 2009; Torner et al. 2001). Downregulation of brain
prolactin receptors increased anxiety-related behavior dem-
onstrating an anxiolytic effect of PRL acting at brain level
(Torner et al. 2001). Furthermore stress-induced increase of
corticotropin secretion was decreased after chronic intracer-
ebroventricular infusion of PRL (Torner et al. 2001). Fujikawa
(2004) showed that PRL levels increase in response to stress
acting on the central nervous system and plays an important
role in helping to protect against acute stress-induced hypo-
calcemia. Taken together, prolactin acting at brain level has to
be considered as a novel regulator of stress response and HPA
axis reactivity in PFC.
The data from the current study indicate that in
addition to abnormalities related to neurons, communi-
cation in chronic stress may be altered due to functional
changes in multiple components of signal transduction
mechanisms. Significant numbers of differentially expressed
genes in our mouse models displayed altered expression in
humans with neurodegenerative diseases. Also of interest was
the decreased expression of Drd1a, Crhr1, Grm5. Its altered
activity has been associated with various human neurological
disorders including schizophrenia, Alzheimer's disease
and Huntington's disease. Regulation may serve as an
adaptive mechanism in response to prolonged stress, and
may be relevant to chronic stress-induced depression in
PFC region.
Conclusions
To summarize, transcriptional profiling revealed evidence of
changes in cell systems that might contribute to structural
and functional abnormalities in the prefrontal cortex in
individuals with different genetic backgrounds. Further
studies are necessary to confirm these findings and to deter-
mine how these changes in gene expression are switched at
different time-points of chronic stress. In genetically predis-
posed individuals, an imbalance in control mechanisms of
gene expression can introduce a bias towards stress-related
brain disease after adverse experiences. New candidate
genes that serve as biomarkers for the prediction of stress-
vulnerable phenotypes should continue to be tested. The
relevance of our findings to human stress, depression, or
anxiety is yet unclear; however, our animal model for chron-
ic stress allowed insights into molecular processes. Further
assessment of alterations in gene expression in brain regions
are required to determine the possible role of stressful situ-
ation during an adaptation or habituation to repeated stress.
In addition, pharmacological validation should be per-
formed to confirm that drugs active in the treatment of
anxiety or depression could reversed the stress-induced gene
expression alteration. It should be noted that despite the
identification of different genes in each mice strain, the
exposure to stress caused a similar biological effect based
on GO database enrichements. The study results show that
many genetic factors, not one allele, determine how an
individual responds to stress and stressful situation.
Limitations
The assessment of the possible chronic stress-related alter-
ations in the PFC transcriptome may be relevant to the
mechanisms involved in stress-induced neuropsychopathol-
ogies. Transcriptomic model reduces the biological com-
plexity of stress response to the genetic level, whereas it
should include genomic, epigenomic, and proteomic levels
in the context of systems biology. Our CMS model assumes
that cortical cells can modify metabolic functions related to
animals' behavior. Another thing is that many metabolic or
cell cycle-related genes were identified among the differen-
tially expressed transcripts certainly points to the possibility
that the observed expression patterns could be only indirect-
ly related to distinct LA and HA mice phenotypes and may
underline differences in other organs, e.g., endocrine system
functions. We speculate that the selection for high and low
SIA may be the basis of strain differences at the brain
metabolic level. Genes are tested at one time point, often
not based on a biological system, e.g., circadian genes and
circadian rhythm. Thus, further studies are needed to deter-
mine how the transcriptomic profiles of particular brain
structures distributing in particular time points of chronic
stress to unravel the differences between adaptation and
disease. Furthermore, development of mouse models where
identified genes are either knocked-down or overactive and
crossing them with models of, e.g., Alzheimer's disease,
Parkinson's disease, multiple sclerosis or amyotrophic
lateral sclerosis, to see if it can influence neurodegen-
eration could reveal their impact on neuropsychopathol-
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ogies. Screening for epigenetics compounds as DNA
methylation and non-coding RNA action that can be
altered is also required. Integration of genomics and
epigenomics could better explain the chronic stress-related
psychopathologies.
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